Correlation Between Nkarta and Summit Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nkarta and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nkarta Inc and Summit Therapeutics PLC, you can compare the effects of market volatilities on Nkarta and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and Summit Therapeutics.
Diversification Opportunities for Nkarta and Summit Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Nkarta and Summit is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of Nkarta i.e., Nkarta and Summit Therapeutics go up and down completely randomly.
Pair Corralation between Nkarta and Summit Therapeutics
Given the investment horizon of 90 days Nkarta Inc is expected to under-perform the Summit Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Nkarta Inc is 1.49 times less risky than Summit Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Summit Therapeutics PLC is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 884.00 in Summit Therapeutics PLC on August 30, 2024 and sell it today you would earn a total of 1,010 from holding Summit Therapeutics PLC or generate 114.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nkarta Inc vs. Summit Therapeutics PLC
Performance |
| Timeline |
| Nkarta Inc |
| Summit Therapeutics PLC |
Nkarta and Summit Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nkarta and Summit Therapeutics
The main advantage of trading using opposite Nkarta and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.| Nkarta vs. Ikena Oncology | Nkarta vs. Eliem Therapeutics | Nkarta vs. HCW Biologics | Nkarta vs. Tempest Therapeutics |
| Summit Therapeutics vs. Nkarta Inc | Summit Therapeutics vs. Cullinan Oncology LLC | Summit Therapeutics vs. Kezar Life Sciences | Summit Therapeutics vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |